Brief: Island Pharmaceuticals Announces Non-Renounceable Pro-Rata Entitlement Offer
26/02/2024 01:25
Feb 26 (Reuters) - Island Pharmaceuticals Ltd ILA.AX :
* UNDERTAKING A NON-RENOUNCEABLE PRO-RATA ENTITLEMENT OFFER
OF 2
NEW SHARES FOR EVERY 5 SHARES
* PRO-RATA ENTITLEMENT OFFER AT AN ISSUE PRICE OF A$0.06 PER
SHARE
Source text for Eikon: ID:nASXc9Ss25
Further company coverage: ILA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic